Literature DB >> 2123165

Penicillin and cephalosporin resistance in gonococci.

C A Ison1, K M Bindayna, N Woodford, M J Gill, C S Easmon.   

Abstract

Non-penicillinase producing Neisseria gonorrhoeae isolated at St Mary's Hospital, London were examined for the prevalence of resistance to penicillin and for decreased susceptibility to cefuroxime. Of the 941 non-PPNG tested 100 (10.6%) were resistant to penicillin (minimum inhibitory concentration, MIC, greater than or equal to 1 mg/l) and were considered to be chromosomally-resistant N gonorrhoeae (CMRNG). Decreased susceptibility to cefuroxime (MIC, greater than or equal to 0.5 mg/l) was detected in 79% of the CMRNG. The CMRNG were also more often prototrophic and of serogroup IB than the remaining non-PPNG. The correlation coefficient for resistance to penicillin and cefuroxime was high, 0.79. Transformation experiments with both genetically-defined strains and transformants obtained using DNA from clinical isolates, showed that increased resistance to cephalosporins was acquired in three steps in close association with penicillin. We think this suggests that the loci controlling resistance to the cephalosporins are identical or closely linked to those controlling penicillin resistance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123165      PMCID: PMC1194556          DOI: 10.1136/sti.66.5.351

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  21 in total

1.  Penicillin-resistant gonococci.

Authors:  E G Dowsett
Journal:  Lancet       Date:  1980-07-26       Impact factor: 79.321

2.  Competition of beta-lactam antibiotics for the penicillin-binding proteins of Neisseria gonorrhoeae.

Authors:  T J Dougherty; A E Koller; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

3.  Acquisition of new genes by oral Neisseria.

Authors:  C Ison; A A Glynn; S Bascomb
Journal:  J Clin Pathol       Date:  1982-10       Impact factor: 3.411

4.  Antimicrobial resistance of Neisseria gonorrhoea in Bangkok: is single-drug treatment passé.

Authors:  S Brown; T Warnnissorn; J Biddle; K Panikabutra; A Traisupa
Journal:  Lancet       Date:  1982-12-18       Impact factor: 79.321

5.  Genetic analysis of drug resistance in Neisseria gonorrhoeae: production of increased resistance by the combination of two antibiotic resistance loci.

Authors:  T W Maier; L Zubrzycki; M B Coyle; M Chila; P Warner
Journal:  J Bacteriol       Date:  1975-11       Impact factor: 3.490

6.  Auxotyping of Neisseria gonorrhoeae isolated in the United Kingdom.

Authors:  C G Copley; S I Egglestone
Journal:  J Med Microbiol       Date:  1983-08       Impact factor: 2.472

7.  Genetic transformation of Neisseria gonorrhoeae to streptomycin resistance.

Authors:  P F Sparling
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

8.  Genetic Transformation as a tool for detection of Neisseria gonorrhoeae.

Authors:  A Janik; E Juni; G A Heym
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

9.  Antimicrobial sensitivity of Neisseria gonorrhoeae. Comparison of penicillinase producing and non-penicillinase producing strains.

Authors:  C Herzog; C A Ison; C S Easmon
Journal:  Br J Vener Dis       Date:  1983-10

10.  Polygenes and modifier genes for tetracycline and penicillin resistance in Neisseria gonorrhoeae.

Authors:  P F Warner; L J Zubrzycki; M Chila
Journal:  J Gen Microbiol       Date:  1980-03
View more
  10 in total

Review 1.  Antimicrobial agents and gonorrhoea: therapeutic choice, resistance and susceptibility testing.

Authors:  C A Ison
Journal:  Genitourin Med       Date:  1996-08

2.  Epidemiology of penicillin-resistant Neisseria gonorrhoeae in Frankfurt, Germany.

Authors:  V Schäfer; R Enzensberger; C Schneider; J Rickmann; H Nitschke-Ozbay; V Brade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-10       Impact factor: 3.267

3.  Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009.

Authors:  Supriya D Mehta; Ian Maclean; Jeckoniah O Ndinya-Achola; Stephen Moses; Irene Martin; Allan Ronald; Lawrence Agunda; Ruth Murugu; Robert C Bailey; Johan Melendez; Jonathan M Zenilman
Journal:  Antimicrob Agents Chemother       Date:  2011-05-23       Impact factor: 5.191

4.  Persistence of two genotypes of Neisseria gonorrhoeae during transmission.

Authors:  I M C Martin; A Ghani; G Bell; G Kinghorn; C A Ison
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 5.  Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy.

Authors:  T Fekete
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

6.  Antimicrobial susceptibilities and serotyping of Neisseria gonorrhoeae in southern Africa: influence of geographical source of infection.

Authors:  C A Ison; N S Roope; Y Dangor; F Radebe; R Ballard
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

7.  Comparison of fleroxacin and penicillin G plus probenecid in the treatment of acute uncomplicated gonococcal infections.

Authors:  A Lassus; L Abath Filho; M F Santos Júnior; L Belli
Journal:  Genitourin Med       Date:  1992-10

8.  The dominance of a multiresistant strain of Neisseria gonorrhoeae among prostitutes and STD patients in The Gambia.

Authors:  C A Ison; J Pepin; N S Roope; E Demba; O Secka; C S Easmon
Journal:  Genitourin Med       Date:  1992-12

Review 9.  An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.

Authors:  Achchhe Lal Patel; Uma Chaudhry; Divya Sachdev; Poonam Nagpal Sachdeva; Manju Bala; Daman Saluja
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

10.  Gonococcal resistance to beta-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus.

Authors:  M J Gill; S Simjee; K Al-Hattawi; B D Robertson; C S Easmon; C A Ison
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.